Hypercoagulability evaluation in congenital red blood cell disorders using thrombin generation assay

Guillaume Feugray; Maximilien Grall; Cécile Dumesnil; Ygal Benhamou; Valery Brunel; Véronique Le Cam Duchez; Agnès Lahary; Paul Billoir

doi:10.1016/j.thromres.2023.03.008

Hypercoagulability evaluation in congenital red blood cell disorders using thrombin generation assay

Thromb Res. 2023 Jul:227:82-85. doi: 10.1016/j.thromres.2023.03.008. Epub 2023 Mar 23.

Authors

Guillaume Feugray¹, Maximilien Grall², Cécile Dumesnil³, Ygal Benhamou⁴, Valery Brunel⁵, Véronique Le Cam Duchez⁶, Agnès Lahary⁷, Paul Billoir⁶

Affiliations

¹ Univ Rouen Normandie, INSERM EnVI UMR 1096, F-76000 Rouen, France; Department of General Biochemistry, CHU Rouen, F-76000, France. Electronic address: [email protected].
² Department of Internal Medecine, CHU Rouen, F-76000 Rouen, France.
³ Department of Pediatric Onco-Hematology, CHU Rouen, F-76000, France.
⁴ Univ Rouen Normandie, INSERM EnVI UMR 1096, F-76000 Rouen, France; Department of Internal Medecine, CHU Rouen, F-76000 Rouen, France.
⁵ Department of General Biochemistry, CHU Rouen, F-76000, France.
⁶ Univ Rouen Normandie, INSERM EnVI UMR 1096, F-76000 Rouen, France; Department of Vascular Hemostasis Unit, CHU Rouen, F-76000 Rouen, France.
⁷ Department of Hematology Laboratory, CHU Rouen, F-76000 Rouen, France.

PMID: 37024320
DOI: 10.1016/j.thromres.2023.03.008

No abstract available

Keywords: Enzymopathy; Hemoglobinopathy; Hemolysis; Hereditary spherocytosis; Hypercoagulability; Sickle cell trait; Thalassemia; Thrombin generation assay.

Publication types

Letter

MeSH terms

Anemia, Sickle Cell*
Erythrocytes
Humans
Thrombin
Thrombophilia* / complications
Thrombophilia* / diagnosis

Substances

Thrombin